Creatine ester anti-inflammatory compounds and formulations

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9833427
APP PUB NO 20110224174A1
SERIAL NO

12723003

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a creatine ester anti-inflammatory compound which may be received by animals and then metabolized into a biologically active form of creatine. The biologically active creatine inhibits the production of chemical mediators, released during an inflammatory response, which are important components in the inflammatory response and the inflammation and pain resulting from physical or chemical trauma to cells and tissue.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA3835 HOLDREGE STREET LINCOLN NE 68583

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Augustine, Samuel C Omaha, US 5 8
McDonald, Thomas L Omaha, US 21 90
Miller, Donald W Winnipeg, CA 38 338
Robinson, Dennis H Omaha, US 6 20
Wagner, Jon C Omaha, US 7 25

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 5, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 5, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00